Abstract
The widespread acceptance of left ventricular assist device (LVAD) implantation in the treatment of heart failure has revolutionized the way end stage heart failure is treated. Advances in LVAD technology combined with a better understanding of patient selection has led to unparalleled survival as well as a reduction in the adverse event profile of these pumps. As our understanding of heart failure continues to grow, there is little doubt that LVADs will continue to play a pivotal role as a therapeutic option for those suffering from heart failure.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 2188-2193 |
| Number of pages | 6 |
| Journal | Journal of Thoracic Disease |
| Volume | 7 |
| Issue number | 12 |
| DOIs | |
| State | Published - 2015 |
| Externally published | Yes |
Keywords
- Left ventricular assist device (LVAD)
- Mechanical circulatory support (MCS)
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine